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Background: Health policymaking is a complex process and analysing the role of evidence is still an evolving area
in many low- and middle-income countries. Where evidence is used, it is greatly affected by cognitive and
institutional features of the policy process. This paper examines the role of different types of evidence in health
policy development in Nigeria.
Methods: The role of evidence was compared between three case studies representing different health policies,
namely the (1) integrated maternal neonatal and child health strategy (IMNCH); (2) oral health (OH) policy; and (3)
human resource for health (HRH) policy. The data was collected using document reviews and 31 in-depth
interviews with key policy actors. Framework Approach was used to analyse the data, aided by NVivo 10 software.
Results: Most respondents perceived evidence to be factual and concrete to support a decision. Evidence was
used more if it was perceived to be context-specific, accessible and timely. Low-cost high-impact evidence, such as
the Lancet series, was reported to have been used in drafting the IMNCH policy. In the OH and HRH policies,
informal evidence such as experts’ experiences and opinions, were reported to have been useful in the policy
drafting stage. Both formal and informal evidence were mentioned in the HRH and OH policies, while the
development of the IMNCH was revealed to have been informed mainly by more formal evidence. Overall,
respondents suggested that formal evidence, such as survey reports and research publications, were most useful in
the agenda-setting stage to identify the need for the policy and thus initiating the policy development process.
International and local evidence were used to establish the need for a policy and develop policy, and less to
develop policy implementation options.
Conclusion: Recognition of the value of different evidence types, combined with structures for generating and
using evidence, are likely to enhance evidence-informed health policy development in Nigeria and other similar
contexts.
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There is an increasing recognition that strong and effect-
ive health systems that are evidence-informed in their
operations are necessary to achieve continued improve-
ment in health outcomes in an efficient and equitable
manner [1, 2]. The incorporation of relevant high-
quality research evidence into the health policy process
has been outlined as a key strategy for improving health
systems worldwide [3–5]. Thus, evidence-informed deci-
sion making has been promoted to aid policy develop-
ment in most countries [6, 7].
The capability of health systems in low- and middle-
income countries to deliver services to the people is se-
verely constrained by polices that are borne out of trial
and error rather than evidence [8, 9]. However, policy-
making processes do not necessary always follow the
clear and straightforward logic of scientific enterprise
[10] and some authors have stated that, when evidence
is used by policymakers, it is greatly affected by cognitive
and institutional features of the political process [11, 12].
Health policymaking, a central element of sustainable
health systems, involves a complex process of interac-
tions between policy actors with different powers, inter-
ests and agendas [13]. Therefore, ensuring the uptake of
evidence for more effective policy and practice is a chal-
lenge for health systems strengthening in most low- and
middle-income countries [14].
Evidence has been described in the literature as “what
constitutes actual or asserted facts planned for use in
support of a conclusion” [15]. Evidence from research
can improve the health policy process, by identifying
new issues for the policy agenda, informing decisions
about policy content and direction, and evaluating the
impact of policy [16–19]. While some authors regard
evidence as mostly scientifically-driven facts, others
argue that evidence can be formal (such as published re-
search or program monitoring and evaluation) or informal
(such as personal experiences, received wisdom and opin-
ions) depending on its process of generation [14, 20, 21].
Analysing the role of evidence in health policymaking
is still an evolving area of research. Whereas the focus of
previous studies on evidence-informed policymaking has
been on the extent to which policies are informed by
evidence, there is limited understanding of the relative
value of different types of evidence in health policy deci-
sions across different policies and varied contexts.
This paper compares the contributions of different
types of evidence in the development of three health
policies in Nigeria and explores the contextual influ-
ences which affected the utilization of evidence in devel-
oping these policies. The results of our study should be
of interest and relevance to the key health policy actors
(such as policymakers, academia, civil society organiza-
tions) who are involved in developing and implementinghealth policies in Nigeria and similar contexts, and are
interested in better understanding and ultimately enhan-
cing the use of evidence in health policy development.
The Nigerian health system and policymaking
Nigeria operates a three-tier level of healthcare – tertiary,
secondary and primary. Provision of healthcare in
Nigeria is a concurrent responsibility of the three tiers of
government – federal, state and local government. How-
ever, because Nigeria operates a mixed economy, private
providers of healthcare have a visible role to play in health
services delivery [22, 23]. The operational levels have dif-
ferent but sometimes overlapping roles and responsibil-
ities. The Federal Ministry of Health (FMOH) provides
tertiary healthcare services as well as technical support to
the state and local government health authorities. They
also regulate the activities of the lower levels. The State
Ministries of Health are statutorily responsible for the
provision of secondary healthcare services and the
provision of technical support for and regulation of pri-
mary healthcare services, while the local governments are
responsible for the implementation of primary healthcare
and provision of services at the primary care level [24].
In response to the very low ranking of the Nigerian
health system in the year 2000 [25], the country
embarked on a Health Sector Reform Program (HSRP)
in 2003. The Federal Ministry of Health and develop-
ment partners such as WHO, UNICEF, Partnership for
Transforming Health Systems (DFID), and the United
Nations Population Fund, among others, initiated and
developed different policies and strategies which aim to
strengthen and improve the functioning of the health
system to become more equitable and efficient in service
delivery and consequently improve health outcomes.
Three of the key policies and strategies that were devel-
oped are the Human Resources for Health (HRH) policy,
the Oral Health (OH) policy and the Integrated Mater-
nal, Newborn and Child Health (IMNCH) strategy.
These were the subjects of investigation of the present
study, which sought to understand the role of evidence
in policymaking.
In Nigeria, the FMOH is responsible for policymaking
and health policies are made at that level by senior gov-
ernment officials with significant contributions from
partners and stakeholders in the public and private sec-
tors. Although the State Ministries of Health can make
policies at their level, most polices at the state level are
adapted from the national level policies and made to fit
the state’s context. A formal process of problem identifi-
cation, agenda setting, policy formulation, and imple-
mentation is used in the policymaking process. However,
these stages are usually interwoven with a series of advo-
cacy meetings, stakeholder consultations, and lobbying.
The National council on health and the Federal Executive
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policies before they can be implemented [24].
The recognition of the usefulness of evidence in pol-
icymaking for effective implementation of the country’s
HSRP evidence-based policymaking initiatives were
established. One such example is the Nigerian Evidence-
Based Health Initiative which was developed to inform a
plan to support a fair and effective primary healthcare
system in Nigeria. However, this program’s focus on only
two States limited the uptake of research to inform pol-
icy in other parts of the country [26].
Amidst political influence of the ruling party in policy-
making, evidence from situation analysis gets used in
agenda setting [27]. However, the use of research evi-
dence to inform policy in clinical decision-making in
teaching hospitals and in policy implementation in
Nigeria has been observed to be very minimal or com-
pletely absent [26, 28].
Methods
This section gives an overview of the study design and
background, describing the conceptual framework used in
the study and giving a brief description of the three pol-
icies and the data collection and analytical methods used.
The conceptual framework (Figure 1) has informed the
identification of the key information areas for the data col-
lection and analysis in this study. Different types of evi-
dence exist in the literature and they can be grouped intoFigure 1 Framework for assessing the role of evidence in policy deveformal and informal [29]. For the purpose of this study,
evidence was defined as information – both formal and
informal – that can be used in supporting (or otherwise) a
conclusion or indicating whether an assumption or prop-
osition is true or valid. Examples of formal evidence
include peer-reviewed research reports and health man-
agement information system and statistical data, whereas
examples of informal evidence include expert knowledge
and experiences as well as outcomes of stakeholder con-
sultations. Evidence can be used in decisions either dir-
ectly (e.g. by indicating effectiveness of a particular
intervention within the same or similar context) or indir-
ectly (e.g. by affecting actors’ values and experiences).
As shown in Figure 1, the role of evidence in health
policies is perceived as interplay between evidence (i.e.
the process of evidence generation, dissemination, and
use) and policy processes (agenda setting, development
and implementation) [20]. The policy actors determine
this interplay through their involvement in evidence and
policy processes, affected by their agendas and practices
[17, 18]. This interplay is affected by the nature of the
policy issue (for example, whether the issue is politically
and socially sensitive and/or controversial), the contents
of a specific policy (i.e. policy options proposed), and the
types and characteristics of evidence available around a
specific policy [4, 18]. All of the above occurs within the
wider context, which includes different national and
international influences [17].lopment.
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The study was undertaken in Nigeria, a West African
country with a population of about 170 million, and
conducted at the Federal Capital Territory of Nigeria,
where all national policies are made.
Study design
This was a retrospective cross-sectional qualitative study
using a case study approach. Three cases were selected
and used to analyse the role of evidence for health policy
development in Nigeria. In this study, a case was defined
as a health policy or strategy developed for an area of
healthcare services (e.g. non-communicable disease, ma-
ternal health, and child health) or a component of the
health system (e.g. human resources for health).
The cases were purposively selected based on the gen-
eral criteria that the policy and/or strategy was estab-
lished within 10 years from the time of the study to
enhance recall, and that it was an area of interest to the
Ministry of Health. In addition, the policies and/or strat-
egies were selected to represent the following three
areas: (1) an area of international prominence (IMNCH
strategy, 2007); (2) a neglected area (OH policy, 2012);
and (3) an aspect/component of the health system (HRH
policy, 2006).
Description of the policies
IMNCH strategy
The Nigerian IMNCH strategy was developed and
launched in 2007. Its overall objective is to reduce ma-
ternal, newborn, and child morbidity and mortality in
line with the millennium development goals (MDGs) 4
and 5. The IMNCH policy was largely a product of a
global agenda to improve maternal and child health in
the MDGs. The political transition to democracy, ac-
companied by an improvement in the budgetary alloca-
tion to health, provided a window of opportunity to
scale-up high impact interventions in maternal and child
health in the country [30]. The strategy was developed
within the framework of the National HSRP to address
the most common conditions responsible for maternal
and under-5 mortality in Nigeria. Its development was
supported by a Partnership Grant from the Partnership
for Maternal, Newborn and Child Health in 2007, in
which the FMOH was tasked with the responsibility of
coordinating actions and partners to accelerate the re-
duction in maternal, newborn and child mortality and
involved academics, health professionals, civil society or-
ganizations (CSOs), and development partners in the
policy development processes.
OH policy
After several failed attempts in the 1990’s and early
2000’s at developing and obtaining final approval for anOH policy, a National OH Policy was developed and fi-
nally adopted in November 2012 in Nigeria. It is
intended to achieve optimal OH for at least 50 % of
Nigerians through five strategies namely by (1) sustain-
able awareness creation, (2) early detection and prompt
treatment of oral diseases using evidence-based inter-
ventions, (3) strategic research, (4) workforce develop-
ment, and (5) co-ordination of OH activities including
institutionalization of modern dental practices. The pol-
icy document was developed through multi-stakeholder
participation of experts in OH, WHO, and medical prac-
titioners in the three tiers of the health system [31].
HRH policy
The HRH policy document was first developed in 2006
by a variety of stakeholders in health made up of public
and private sector players following world health reports
devoted to addressing the global HRH crisis [31]. An on-
going national health sector reform program also em-
phasized the poor maternal mortality ratio and under-
five mortality rate as well as other anomalies in the
health system and was geared towards improving the
country’s poor health indices. The policymakers using
the national reform and the positive political climate as
a platform were motivated to develop the policy to ad-
dress a number of key challenges in HRH, including
planning, recruitment, production, utilization, and reten-
tion of health workers.
Data collection methods
The data was collected between December 2012 and July
2013. Two methods were used to collect data for this
study: document review and in-depth interviews.
Document review
Document reviews were used to identify the different
evidence available around a particular policy and inform
the development of the initial list of respondents for the
study. A total of 27 documents were reviewed, covering
all three case studies. Documents included in the review
were key policy statements, policy dissemination docu-
ments, published consultancy reports, published and un-
published monitoring and evaluation reports, academic
publications, research reports, policy briefs, grey litera-
ture (e.g. consultancy reports), and health statistics in-
cluding health management information system reports
and country-level publications on websites of the rele-
vant agencies (e.g. FMOH, WHO). In order to retrieve
relevant national documents and academic publications,
an extensive search was carried out on academic data-
bases (such as PubMed and Cochrane), institution/
organization libraries and search websites (such as Goo-
gle scholar), using key words such as Nigerian health
policy, human resources for health policy, integrated
Table 1 Participant types and number interviewed
Participant types IMNCH OH HRH
Public policymakers and government officials 5 3 5
Academics/Researchers 1 4 1
Professional groups 1 0 1
Civil society organizations 1 1 2
Development partners 2 1 2
Health workers 0 0 1
Total 10 9 12
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Expert recommendations and citation pearling were also
used to identify and retrieve documents.
Once the documents were identified, the executive
summary/abstract of each document was reviewed to
identify its relevance to the particular policy. The inclu-
sion of documents in the review was guided by relevance
of the evidence to the policy issues as perceived by re-
searchers and availability of the document during the tim-
ing of the policy development. Relevant information on
extent and types of evidence used in policy development
and key contextual influences on evidence use was ex-
tracted from the documents and summarized according to
the key components in the conceptual framework (evidence
process and use, context, actors, and policy process). A
standardized proforma with these key components was
used for the extraction, which was structured around the
four components of the conceptual framework.
In-depth interviews
In-depth interviews were conducted to explore percep-
tions of usefulness of evidence in policy/strategy devel-
opment and the key contextual influences on evidence
use for policymaking. Detailed information was collected
from policy actors such as government policymakers,
representatives of CSOs, health workers, development
partners, and academics. The list of respondents for in-
terviews was developed using purposive sampling (based
on their role in developing health policies and their
availability for interview) and informed by review of key
policy documents around each of the three case studies,
researchers’ knowledge of the actors’ involvement in pol-
icy development, and initial meetings with the key stake-
holders (as part of consultation in selecting a policy
within each case study). The list of respondents was con-
tinuously updated throughout data collection using the
snowballing technique.
The interviews were guided by a semi-structured ques-
tion guide focused on respondents’ role and the under-
standing and perceptions of the role of different types of
evidence in health policy development. Most interviews
were face-to-face and, in situations where respondents
could not be reached within the interview period, tele-
phone interviews were conducted (two interviews in the
OH policy case study and one in the IMNCH case study
were conducted by telephone). The respondents were as-
sured of confidentiality and anonymity during recruit-
ment. This enabled the respondents to give extensive
information on their knowledge, experiences and percep-
tions on role of evidence in policy formulation.
A total of nine policy actors were interviewed for OH,
10 for IMNCH, and 12 for HRH. A summary of partici-
pant types and number interviewed is presented in Table 1.
New participants were interviewed until saturation wasreached for the respective case studies. Where key actors
were not available for interviewing (e.g. retired), their im-
mediate colleagues possessing knowledge of the policy
development were approached. All interviews were audio-
recorded with informed consent obtained prior to the
interview (Table 1).
Data analysis
A thematic framework analysis was performed, which in-
cluded stages of familiarization with the data, coding,
indexing and charting data, and mapping and interpret-
ation [32]. The findings from the various documents
reviewed were synthesized based on the thematic areas
and analyzed. All audio recorded interviews were tran-
scribed by the interviewers. A coding tree was used to
code the transcriptions according to relevant thematic
areas, such as (1) respondents perception of evidence,
(2) types and characteristics of evidence, (3) role of dif-
ferent types of evidence, (4) actors, and (5) contextual
influences on evidence and policy processes. NVivo10
software was used to aid the data coding and analysis.
Ethical considerations
Ethics approval for this study was obtained from the
University of Nigeria Teaching Hospital ethical review
board, before the commencement of the in-depth inter-
views. Each respondent also gave informed consent be-
fore the in-depth interviews were undertaken.
Results
This section gives a brief description of the policy/strategy
development context for the three case studies and high-
lights similarities and differences between the three case
studies in the policy development process. It also presents
the types of evidence used in policy/strategy development
and the influences of context, respondents’ understanding
of the concept, and robustness of evidence on evidence
use in development of the policies and strategy.
Context of policy/strategy development
Based on responses obtained from our interviews, we
observed that the three policies were developed amidst
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and HRH policies were already familiar and well dis-
cussed topics, with previous policies developed. How-
ever, the OH policy was regarded as neglected with
uncoordinated and haphazard attempts at previous pol-
icy developments, which failed after the first OH policy
in 1995. All three policies generally followed a formal
policy development process which consisted of agenda
setting, information gathering, policy formulation, ap-
proval, and review and validation. Our respondents’,
however, reported that this process did not follow a lin-
ear fashion but was iterative and interspersed with stages
of lobbying and advocacy, especially with the HRH pol-
icy (Table 2).
Analysis of interview data revealed that various factors
influenced the different stages of policy development.
Three factors influenced the agenda setting stage of all
three policies: global as well as national considerations
and policy framework. The national policy guideline/
framework influenced the drafting of IMNCH and HRH
policy documents, though this is not the case in the OH
policy formulation, where real-life experiences affected the
policy drafting and revision stages. In all three policies,
and in the OH policy case in particular, both national and
global considerations had substantial influences on the
probability of policy being approved. The international
clamour for the need of an OH policy by global actors, for
example by WHO, and the persistence of one specific na-
tional actor, are all factors that were found to have influ-
enced the likelihood of policy approval.
Respondents’ perception of evidence
Across the three case studies, participants perceived evi-
dence processes as a formal process of gathering informa-
tion to inform decisions. However, different stakeholders
appeared to adopt diverse and often conflicting views of
what constitutes evidence, as their understanding of theTable 2 Context of development of the three cases under stud
IMNCH strategy OH policy
Had high international prominence and
was key in most national discourses
Regarded as a neglected area
health sector of the country
The need to produce a comprehensive plan
of action to address the high maternal and
child mortality indices in the country health
This policy was thus develope
on the high oral disease burd
The need for an integrated strategy to
promote continuum of care for mother
and child
The desire of the relevant sta
standardize practice, organiza
delivery of oral health service
the country
Formal policymaking process (agenda setting to development and final appr
Existing strategic framework (national
health sector reform plan) was used
to guide policy development
No coordinated strategy fram
health services
Failure of previous attempts t
oral health policyconcept seemed to reflect their personal experiences. We
did not identify a single dominant common definition of
‘evidence’, but rather a plurality of interpretations, but this
was not highlighted as an issue of concern by the inter-
viewees. In some cases, perceptions of evidence were
broad and in others it was linked synonymously with re-
search, albeit with less certainty about the meaning of the
word ‘evidence’. Most respondents gave a definition of evi-
dence which is synonymous with research.
“My understanding of evidence use is having concrete
data that has been collected through a process that is
considered legitimate and you give reference to that
data. It could have been a survey.” (HRH, CSO; OH,
Academia)
However, a minority of respondents also gave a
broader definition of evidence, suggesting that this can
also include informal types:
“Evidence is like a mere idea that have been harvested
and shows where you are, and informs what you
intend to subsequently do. In this context, it should
prove there is a situation.” (HRH, Policymaker)
Types of evidence used
Ten types of evidence were perceived by the respondents
as being used to develop policies within all three case
studies. These are survey reports, research publications,
national and international policy documents, systemic
review reports of programs, proceedings from expert
consultation meetings, experience and opinions of ex-
perts and policymakers, epidemiological reports and
documents on lessons learned from international experi-
ences, and best practice guidelines (Table 3).
Both formal and informal types of evidence informed
the development of the three policies, though oury (IMNCH, OH, and HRH)
HRH policy
in the This was a key aspect in most national and international
political debates as it cuts across all aspects of health
d based
en in Nigeria
This policy was developed based on the inadequate
production, mal-distribution of the available workforce,
and the increasing brain drain resulting in shortage of
critically needed healthcare professionals
keholders to
tion and
s across
oval of policy)
ework for oral Existing strategic framework (national health sector
reform plan) was used to guide policy development
o develop an
Table 3 Types of evidence used across the three case studies
Types of evidence used Case studies
IMNCH OH HRH
Survey reports, situation analysis, national data sets, institution data sets ✓ ✓ ✓
Research publications (international and national) ✓ ✓ ✓
Existing policy documents (national) ✓ X ✓
Systematic review reports ✓ X X
Epidemiological reports ✓ X X
Proceedings of expert consultation meetings ✓ ✓ ✓
Lessons from international experience and best practice guidelines (policies and publications) ✓ ✓ X
Health management and information system data X X X
Monitoring and evaluation reports X X X
Expert and policymaker opinions and experiences ✓ ✓ ✓
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larger role. The quote below depicts this statement.
“Basically, evidence from program implementation,
research findings, program reports, I think this are for
me the most important.” (IMNCH, Policymaker)
As shown in Table 3, formal evidence (national and
international) played a more prominent role in the de-
velopment of all three policies. Informal evidence
seemed to play a role in HRH and OH policies more
than in IMNCH policy.
Amongst all evidence used, the one considered to be the
most important by the majority of respondents across the
three cases were findings from national surveys (such as
baseline surveys or situation analysis) because they were
context-specific, timely and gave a true picture of what
was on the ground. Most respondents felt that the meth-
odological rigor, availability of survey reports, relevance,
and ease of obtaining the information from these surveys
were also what made it especially useful.
“The evidences we had were based on research
activities and surveys which are national in their
scope, and then …… they were quite extensive and
rigorous” (OH, Academia).
However, there were a few disparate views as regards
labelling this singular type of evidence as the most im-
portant, because according to the respondents, “all types
of evidence generated complements each other, we cannot
say one is the best” (HRH, Academia). For example, in
the HRH case study, evidence obtained from opinions
and experiences of experts in the field were considered
important by some respondents, especially the policy-
makers. They claimed that this form of evidence helped
to augment the findings from the baseline survey. In
IMNCH, published research findings, especially thosefrom a series of publications showing evidence of high
impact interventions for maternal and child survival
published in the Lancet [33], were important by giving
an insight into best practices for maternal and child
health issues and added to the body of evidence in
developing the policy.
“For me the ones I thought were most important was
evidence of effectiveness of high impact intervention
from the Bellagio [Lancet [33]] survival series”
(IMNCH, Policymaker).
An analysis of the various responses highlight the use
of a wide breath of evidence-informed policies, which in-
cluded both formal and informal evidence. The nature
of methodology (rigorous or not) informed the likeli-
hood of evidence.
“Evidence am looking more at empirical
data….empirical data. But beyond looking at
empirical data, I am also interested in the process of
gathering that data.” (DP, CSO)
In response to our questions on what evidence the re-
spondents consider as robust, we documented eight
characteristics of robust evidence as perceived by our re-
spondents, namely quality/accuracy, credibility, relevance,
accessibility, comprehensiveness, context specificity, of na-
tional scale, and representativeness of evidence. The fol-
lowing quotes substantiate these findings:
“My understanding of evidence use is having concrete
data that has been collected through a process that is
considered legitimate and you give reference to that
data. It could have been a survey. I mean it’s a fact
that figures don’t lie. — figures about distribution,
retention, rural–urban disparity and all that stuff.”
(HRH, CSO)
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use data that is representative of the whole country.”
(IMNCH, Policymaker).
The issue of comprehensiveness of evidence was em-
phasized only by the respondents in the IMNCH case
study and evidence being of national scale and representa-
tiveness was emphasized in the development of the OH
policy. The importance of all other characteristics of evi-
dence was shared by respondents across the three policies.
Role played by different types of evidence in policy
development across case studies
The various types of evidence mentioned previously in-
formed different stages of the policy development
process in the three case studies (Table 4). Survey re-
ports and research publications informed the policy de-
velopment process across the case studies. These survey
reports and research publications were most useful in
the agenda setting stage because they provided the push
needed to bring the topic on the policy agenda thus ini-
tiating the first stage of the policy development process.
“Well, the survey found many discrepancies in the
ratio of health workforce in relation to all health
sectors. It was terrible. When the data was presented
we shuddered. When we saw from literature review
what other countries are doing, we were challenged to
do something” (HRH, Policymaker)
In addition, journal publications from the Lancet series
in IMNCH policy [33] and WHO publications in OH
policy [34] were used to a large extent in the problem def-
inition stage and helped buttress the data obtained from
the surveys. They provided data on best practices for the
OH and IMNCH policies, which helped in development
of the policy (Table 4).Table 4 Role played by different types of evidence in three cas
Stages of policy
development
Evidence used
IMNCH policy
Information gathering National survey reports, institutional
data, epidemiological reports, research
publications, aggregated data from states
Agenda setting Publications of best practices, e.g. Lancet
series, systematic review reports, research
publications
Development of policy draft Expert consultation reports, existing
policy documents
Review of policy draft Expert consultation reports, synthesis
of previously collected information
Approval of policy document Expert consultation reportsOn the other hand, reports from expert consultations
were perceived by the respondents as useful in the policy
drafting stage because they now built on the information
provided by the surveys to improve the body of evidence
used. The expert consultations brought in a practical
aspect to the policy development because most of the
evidence generated from this source was based on
hands-on experience of the stakeholders, which added
value to the evidence obtained, as illustrated below:
“What happened was there was a stakeholders
meeting and we got a lot of information from them, sat
down together to brain storm on the information and
that was what was utilized in the final writing” (OH,
Policymaker)
The situation analysis and survey reports were useful
to different actors for different reasons: to the aca-
demics, these types of evidence gave a credible idea of
the situation and provided guidance to the direction of
their technical input; the government policymakers
found them useful in providing information that was
representative of the country and context appropriate; to
the development partners, they provided useful informa-
tion to guide decisions of resource allocation and tech-
nical input; and, finally, the CSO’s found these useful for
providing evidence of current health situations in terms
of figures and numbers that would enable more effective
lobbying.
Key influences on evidence use
We found that global considerations, existing policy
guidelines, and burden of health needs were the major
contextual influences which helped set the agenda for
the three health policies. The utilization of evidence in
each of these three policies was influenced by different
factors from these three broad areas (Table 5).e studies
OH policy HRH policy
Institutional data, research
publications, lessons learnt
from international experience
Institutional data, situation
analysis reports, research
publications
WHO publications, national survey
reports, research publications,
publications of best practices
Situation analysis reports,
research publications
Experiences and opinions of
experts, expert consultation
reports
Expert consultation reports,
experiences and opinions
of experts, existing policy
documents
Expert consultation reports,
synthesis of previously collected
information
Expert consultation reports,
synthesis of previously
collected information
Expert consultation reports Expert consultation reports
Table 5 Influence of context on evidence use
Factors IMNCH OH HRH
Global considerations/movement WHO partnership for maternal, newborn
and child health movement provided
support for partner countries to develop
an IMNCH strategy
There was an international
push towards development of
oral health policies in Africa
Inability to meet the international
standard for health worker to
population ratio
International move to resolve
HRH crisis especially in Africa
Existing policy/guideline/frame
work
Prior existence of the reproductive health
policy and child health policy
Fragmented drafts of previously
written policies which had not
been adopted
Existence of health sector reform
plan which emphasized the need
for equitable distribution and health
worker retention
Existence of implementation strategy
for the child health policy
This was the first OH policy
adopted in Nov 2012
National considerations Ongoing National health sector reform
plan which showed areas of need
Presence of policy champion Policy champion and ongoing health
sector reform plan
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was identified by the respondents as an important con-
textual influence which increased the use of evidence in
all three policies. For example, the international push for
the development of the OH policy was predominantly
from WHO, which had directed its African region coun-
tries to all develop an OH policy as part of their regional
OH strategy [35].
“The WHO directive and with Nigeria being a major
stake holder in the WHO, I think that facilitated the
approval for developing of Oral Health Policy in the
country.” (OH, Academia).
All four previous attempts at formulating an OH
policy in Nigeria in the past three decades were un-
successful. The first three attempts (between 1984
and 1999) failed because of an unfavourable political
environment during military rule, whereas a fourth
attempt at developing an OH policy (2004–2009) failed
due to non-observance of national stipulations for policy
development [36].
Discussion
Multiple evidence types were used in the development
of three health policies in Nigeria. Policymakers and
other actors, though guided by their perceptions of ro-
bust evidence to make decisions on which evidence to
use, were also perceived importance of experiences and
expert opinions possibly giving room for a ‘non-scien-
tific’ angle to policymaking. Eight characteristics of ro-
bust evidence were perceived to be important by policy
actors in all policies. These qualities were attributed to
nationally-generated evidence, such as reports of sur-
veys, and other datasets generated through government
machinery. Context was an important determinant of
perceived characteristic of robust evidence. The fact that
methodological rigor was mentioned by some policy-
makers as a characteristic of robust evidence suggests thatthese individuals have some understanding of what con-
stitutes methodological rigor and this degree of
understanding reflects their background.
Different stakeholders seemed to adopt diverse defini-
tions of what represents evidence – possibly influenced
by their personal experiences in policy development. Al-
though the respondents never identified this lack of a
shared definition of evidence as an issue of concern,
it is clear that an unresolved tension existed among
our informants, as people kept referring to different
concepts and attributes of what represents evidence
for and about policy.
The actors’ understandings of evidence appear also to
have influenced which evidence was used. The fact that
most respondents defined evidence as a formal entity
where legitimate and concrete data are collected and
processed could be a reflection of why formal types of
evidence (research and survey data and reports, etc.)
were used most frequently in setting the agenda. For ex-
ample, in the OH and HRH case studies, the use of situ-
ation analysis reports, survey reports, and published
research confirmed this potential relationship between
perception of what constitutes evidence and its use. This
is also true for IMNCH, where evidence of best practices
from international publications constituted the main
form of evidence used. In addition, it could be that the
actors’ beliefs had been pre-shaped by the public policy-
making structure in the country which seems to rely on
documented evidence to be used to either make a point
or influence a policy decision. This finding is similar to
what Sutcliffe and Court reported [37], namely that ac-
tors’ ideologies, principles and political orientation ul-
timately affect how and what types of evidence get used
for policymaking. This became more obvious in our
study because the perception of the government policy-
makers, “who were the drivers of the three policies”, was
that stakeholders’ experiences were a very important
form of evidence which led to its use in the OH and
HRH policy formulation.
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public policy informed by rigorously tested established
evidence in the design, implementation and refinement
of policy [38]. Our study shows that a wide breadth of
evidence was used in formulating the three policies in
Nigeria. However, more emphasis was laid on the formal
type of evidence and most evidence was used at the
agenda-setting and less during the development stage.
This could be due to the fact that Nigeria has a docu-
mented process for policy development as shown by the
different strategic frameworks and the Nigerian constitu-
tion (FMOH) in addition to the international drive to-
wards evidence-based policymaking.
Similar types of evidence were generated to formulate
the three policies. This suggests that the same type of
evidence is generally accessible to those formulating pol-
icies in the country or there is limited knowledge about
the various types of evidence that are available and pos-
sibly gathered for policymaking. There may therefore be
a need to enlighten those involved in policymaking
about what constitutes evidence so as to broaden the
scope of types of evidence used for future policymaking.
Evidence use for policy agenda setting appeared to be ex-
tensive and adequate in all three cases and the situation
analysis and survey reports were useful to different actors
for different reasons. Our study revealed that evidence was
used as input to decision-making for technical experts, con-
ceptualizing the situation for government policymakers,
implementing partners and CSOs, and persuading actors to
buy in for certain policies, all of which was achieved by
CSO lobbying. This is similar to findings by Shadish et al.
[39], who also revealed that evidence could be used for
three purposes – instrumental (input to decisions making),
conceptual (helping towards a better understanding of the
subject matter), and strategic (to persuade other actors as
the means to attain a specific goal).
Formal evidence, such as research findings and data sets,
were used in agenda setting, because of their context rele-
vance, rigour and timeliness. The ease and availability of
obtaining information from these sources of evidence also
played a role in their use for policy/strategy making.
According to Shaxson [40], some key characteristics
of evidence which influence whether it is used include
quality/accuracy, credibility, relevance, and accessibility to
policymakers. In addition to these characteristics, compre-
hensiveness, context relevance, and representativeness of
evidence were considered characteristics of robust evi-
dence in our study.
Formal evidence, like research and survey and program
reports, were used in policy development, while there was
little or no mention of other types of formal evidence such
as health management information system data. This could
be attributed to their perceived unavailability. Thus, only
evidence considered reliable or accessible and trulyreflecting which evidence the policy actors felt was the best
was used to establish the need for policy development.
The informal type of evidence used, which was the ex-
pert consultation meetings, emphasized the fact that evi-
dence was subject to what the actors considered
important and relevant and also what they perceived evi-
dence to be. The fact that some respondents – such as
influential government policymakers – felt this form of
evidence was very important, was synonymous with its
use in the drafting and writing up of the policy, even
though other stakeholders, like academics and CSO’s,
felt less strongly about this form of evidence. However,
this use of evidence is consistent with what was reported
in previous studies [20], which observed that apart from
formal documented evidence from data and research, ex-
perience of various stakeholders and decision makers can
also be influential in the policy development process.
Contextual factors influenced policy formulation and
evidence use for the three case studies, albeit differently.
For instance, the interests of international partners and
agencies gave the initial push for prioritization of mater-
nal and child health on the national agenda, and the
subsequent development of the IMNCH strategy.
Whereas the need to develop an OH policy was under-
scored by the absence of a strategic framework for OH
services and previous failed attempts at policy formula-
tion, rather than an international push. National surveys
and empirical studies that clearly identified health prob-
lems, policy gaps and bottlenecks, and made recommen-
dations of strategies or guidelines for implementation,
provided useful guidance during the process of drafting
policy contents. A central influence on evidence process
across case studies in Nigeria was the recognition of the
global movement on evidence-based best practices. Al-
though somewhat different in its nature to international
treaties such as the MDGs, this movement triggered a
national awareness of the need to develop comprehen-
sive, evidence-informed policies and plans of action.
Though similar to what was found in India as part of the
wider study, evidence use is being progressively recog-
nized as a highly contingent process that varies across
settings and time [41, 42]. In this sense, context can be
seen as a potential determinant of the use of evidence.
The reliance on international evidence for providing
new policy ideas, in this case, may be linked to the stra-
tegic role policy actors (e.g. WHO) played in identifying
and disseminating evidence for informing the policy
process. A wider range of influences were identified at
the agenda-setting stage than during policy formulation
and approval. This is similar to what other authors
found [20]. Similar to the above, multiple influences,
often comprising international and national factors, can
ensure that a policy is finally approved, as was the case
with the successful approval of OH policy following
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tors affected policy formulation, though a clear guideline
or a framework can mainstream policy processes and
can potentially provide a framework for ensuring actors’
participation and possibly addressing any discourse
(such as different views of robust evidence).
Our findings suggest that recognition of the value of
formal and informal types of evidence, combined with
structures for generating and using evidence, are likely
to facilitate generation of evidence for policy develop-
ment. Evidence that is easily accessible to policymakers
and is in a user-friendly form, will most likely be used in
policy development. Furthermore, involvement of tech-
nical experts (including researchers) who have an appre-
ciation for evidence and its use in policymaking, also
contributes to evidence-based policymaking.
Several potential implications for policy and practice
emerge from our study, which should be of relevance to
the policy actors interested in improving the role of evi-
dence in health policymaking in Nigeria and other similar
contexts. First, different policy actors need to be aware of
the understanding of the concept of evidence by others, in-
cluding their preferences for robust evidence. In the longer
term, different policy actors can work towards developing
a shared understanding of robust evidence. Secondly, the
knowledge of different types of evidence and their import-
ance would enhance the use of both formal and informal
types of evidence which should improve the quality of evi-
dence generated for policy. Thirdly, a decentralized con-
sultative approach using a variety of mechanisms to obtain
wider participation and input from a range of stakeholders
at all levels, including national and sub-national, govern-
ment and non-government, as well as the public groups.
These mechanisms include consultations with multi-
stakeholder groups and expert working group meetings.
A possible limitation of the study is that we relied
mostly on the understanding of the role of evidence as
perceived by the policy actors as this creates the potential
for recall bias. Whilst we attempted to look for signs of
evidence use in policy documents (e.g. references to spe-
cific studies), the systematic comparison of available ver-
sus the used evidence was outside the scope of this study.
Conclusion
Different types of evidence were used to formulate policy
in the three case studies. Most evidence generated was
used to set the agenda and policy discourse. Apart from
the IMNCH strategy where evidence was used to select
interventions, we did not find any indication that suggest
evidence was used to determine policy options (‘evidence
on policy’) for the OH and HRH policies.
Relevance, comprehensiveness, availability, context-
appropriateness, affordability, methodological rigor, timeli-
ness, and representation of country situation werecharacteristics of robust evidence as perceived by policy-
makers. Although it is unlikely that these characteristics
of robust evidence would be met at the same time, re-
search organizations and academics in the country are
challenged with the need to generate evidence that meet
these criteria. Policymakers and influencers, on the other
hand, need to exercise some judgment about priorities
and preferences in the selection of available evidence for
policymaking.
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